Loading clinical trials...

Trial of Additional Measles Vaccine to Reduce Child Mortality | Clinical Trials | Clareo Health

COMPLETEDPhase 4NCT01644721

Trial of Additional Measles Vaccine to Reduce Child Mortality

Background: All observational studies and a few randomised controlled trials (RCT) suggest that early measles vaccine (MV), in particular an early two-dose strategy, has a much better effect on overal...

Lead sponsor: Bandim Health Project•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

COMPLETED

Do Childhood Measles and DTaP Vaccination Decrease the Mortality Rate Caused by COVID-19 in OECD Countries?

NCT04468802 · Covid19, Measles Vaccine, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 11, 2026Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment3,750

Start dateJul 2012

Last updatedFeb 11, 2026

Condition

Measles Vaccine

Locations shown

Bandim Health Project

Bissau

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 11, 2026Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions